Why the study?
The CHA2DS2-VASc score has drawn interest for predicting adverse coronary events, prompting evaluation of its predictive value for in-stent restenosis after drug-eluting stent implantation.
Does the preprocedural CHA2DS2-VASc score predict in-stent restenosis in patients after drug-eluting stent implantation?
Does the preprocedural CHA2DS2-VASc score predict in-stent restenosis in patients after drug-eluting stent implantation?
The CHA2DS2-VASc score, traditionally used for atrial fibrillation stroke risk, demonstrates good predictive value for in-stent restenosis following drug-eluting stent implantation.
Answers are grounded in this paper and cite their sources.
Higher CHA2DS2-VASc scores were associated with ISR after DES; leaves open whether it improves risk stratification beyond existing models.
Objective: The CHA2DS2-VASc score, a system which has been initially recommended for the assessment of thromboembolic risk in patients with atrial fibrillation (AF), arouses attention in the field of adverse coronary events. The purpose of this study was to explore the predictive value of preprocedural CHA2DS2-VASc score on ISR in patients after drug-eluting stent (DES) implantation. Methods: To further investigate the relationship between CHA2DS2-VASc scores and ISR after DES, a retrospective study of DES was carried on. Additionally, the preoperative variables for the ISR and control groups were contrasted. Predictive factors were chosen using the optimal subset regression. We validate the model using internal validation. The prediction model was evaluated using the receiver operator characteristic (ROC) analysis. Results: We used a 3:7 ratio to create an experimental group and a validation group, and then ran a stepwise regression with the data from each of the two groups. The results showed that CHA2DS2-VASc score was an independent risk factor for ISR in both the experimental (p = 0.0139) and validation groups (p = 0.0014), and both had significant predictive value for ISR. The area of the ROC curve was greater than 0.5 in both groups (AUC = 0.78, 0.719, respectively) indicating that the model fit was good in both groups. Conclusion: The CHA2DS2-VASc score is a reliable predictor of in-stent restenosis (ISR) after DES implantation.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: